Cargando…

Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients

BACKGROUND: Following the high morbidity and mortality due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in New Orleans, Louisiana, we sought to assess progress toward herd immunity. METHODS: Ochsner Health employees and patients who volunteered for Abbott SARS-CoV-2 imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabagambe, Edmond K, Velasco-Gonzalez, Cruz, Henry, Marcia B., Fort, Dan, Wu, Qingli, Sossaman, Gregory, Laborde, Yvens, Price-Haywood, Eboni, Roberts, W. Mark, Seoane, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Southern Society for Clinical Investigation. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485713/
https://www.ncbi.nlm.nih.gov/pubmed/34606754
http://dx.doi.org/10.1016/j.amjms.2021.09.006
_version_ 1784577590783115264
author Kabagambe, Edmond K
Velasco-Gonzalez, Cruz
Henry, Marcia B.
Fort, Dan
Wu, Qingli
Sossaman, Gregory
Laborde, Yvens
Price-Haywood, Eboni
Roberts, W. Mark
Seoane, Leonardo
author_facet Kabagambe, Edmond K
Velasco-Gonzalez, Cruz
Henry, Marcia B.
Fort, Dan
Wu, Qingli
Sossaman, Gregory
Laborde, Yvens
Price-Haywood, Eboni
Roberts, W. Mark
Seoane, Leonardo
author_sort Kabagambe, Edmond K
collection PubMed
description BACKGROUND: Following the high morbidity and mortality due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in New Orleans, Louisiana, we sought to assess progress toward herd immunity. METHODS: Ochsner Health employees and patients who volunteered for Abbott SARS-CoV-2 immunoglobulin G (IgG) antibody test between March 1 and May 1, 2020 were included. We estimated IgG prevalence and used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for variables associated with IgG test status. RESULTS: Of the 13,343 participants with IgG test results, 78.6% were women, 70.6% were non-Hispanic White, 21.1% non-Hispanic Black, 2.9% Hispanic Americans and 5.4% belonged to other races. Overall, 7.99% (95% CI: 7.53-8.45%) of the participants tested IgG positive. In age-, sex- and body mass index (BMI)-adjusted analyses, non-Hispanic Blacks were 2.7-times more likely to test positive than non-Hispanic Whites (OR=2.72; 95% CI: 2.33-3.19). Corresponding ORs (95% CIs) were 1.29 (0.84-1.99) for Hispanic Americans and 1.22 (0.85-1.75) for Other race/ethnicities. Compared to participants in administrative occupations, physician assistants (OR=7.14; 95% CI: 1.72-29.6) and therapists (OR=4.74; 95% CI: 1.49-15.03) were significantly more likely to have IgG antibodies while the association among nurses was not significant (OR=2.35; 95% CI: 0.96-5.77). Relative to 1.40, the test threshold for positivity, our measurements indicate a strong immune response (5.38±1.69), especially among those with a higher BMI. CONCLUSIONS: SARS-COV-2 IgG antibodies were prevalent only in 8% of the participants. IgG prevalence was highest among non-Hispanic Blacks and participants with higher BMI but was lower among older participants.
format Online
Article
Text
id pubmed-8485713
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Southern Society for Clinical Investigation. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84857132021-10-04 Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients Kabagambe, Edmond K Velasco-Gonzalez, Cruz Henry, Marcia B. Fort, Dan Wu, Qingli Sossaman, Gregory Laborde, Yvens Price-Haywood, Eboni Roberts, W. Mark Seoane, Leonardo Am J Med Sci Clinical Investigation BACKGROUND: Following the high morbidity and mortality due to Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infections in New Orleans, Louisiana, we sought to assess progress toward herd immunity. METHODS: Ochsner Health employees and patients who volunteered for Abbott SARS-CoV-2 immunoglobulin G (IgG) antibody test between March 1 and May 1, 2020 were included. We estimated IgG prevalence and used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for variables associated with IgG test status. RESULTS: Of the 13,343 participants with IgG test results, 78.6% were women, 70.6% were non-Hispanic White, 21.1% non-Hispanic Black, 2.9% Hispanic Americans and 5.4% belonged to other races. Overall, 7.99% (95% CI: 7.53-8.45%) of the participants tested IgG positive. In age-, sex- and body mass index (BMI)-adjusted analyses, non-Hispanic Blacks were 2.7-times more likely to test positive than non-Hispanic Whites (OR=2.72; 95% CI: 2.33-3.19). Corresponding ORs (95% CIs) were 1.29 (0.84-1.99) for Hispanic Americans and 1.22 (0.85-1.75) for Other race/ethnicities. Compared to participants in administrative occupations, physician assistants (OR=7.14; 95% CI: 1.72-29.6) and therapists (OR=4.74; 95% CI: 1.49-15.03) were significantly more likely to have IgG antibodies while the association among nurses was not significant (OR=2.35; 95% CI: 0.96-5.77). Relative to 1.40, the test threshold for positivity, our measurements indicate a strong immune response (5.38±1.69), especially among those with a higher BMI. CONCLUSIONS: SARS-COV-2 IgG antibodies were prevalent only in 8% of the participants. IgG prevalence was highest among non-Hispanic Blacks and participants with higher BMI but was lower among older participants. Southern Society for Clinical Investigation. Published by Elsevier Inc. 2022-01 2021-10-01 /pmc/articles/PMC8485713/ /pubmed/34606754 http://dx.doi.org/10.1016/j.amjms.2021.09.006 Text en © 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Clinical Investigation
Kabagambe, Edmond K
Velasco-Gonzalez, Cruz
Henry, Marcia B.
Fort, Dan
Wu, Qingli
Sossaman, Gregory
Laborde, Yvens
Price-Haywood, Eboni
Roberts, W. Mark
Seoane, Leonardo
Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients
title Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients
title_full Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients
title_fullStr Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients
title_full_unstemmed Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients
title_short Prevalence, Distribution and IgG Antibody Levels Associated with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Health-System and Community-Based Employees and Patients
title_sort prevalence, distribution and igg antibody levels associated with severe acute respiratory syndrome coronavirus 2 (sars-cov-2) among health-system and community-based employees and patients
topic Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485713/
https://www.ncbi.nlm.nih.gov/pubmed/34606754
http://dx.doi.org/10.1016/j.amjms.2021.09.006
work_keys_str_mv AT kabagambeedmondk prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT velascogonzalezcruz prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT henrymarciab prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT fortdan prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT wuqingli prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT sossamangregory prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT labordeyvens prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT pricehaywoodeboni prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT robertswmark prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients
AT seoaneleonardo prevalencedistributionandiggantibodylevelsassociatedwithsevereacuterespiratorysyndromecoronavirus2sarscov2amonghealthsystemandcommunitybasedemployeesandpatients